Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | |
| Cash Flows From Operating Activities | |
| Net Income | -13,180 |
| Depreciation Amortization | 499 |
| Accounts receivable | 430 |
| Accounts payable and accrued liabilities | 438 |
| Other Working Capital | -12 |
| Other Operating Activity | -600 |
| Operating Cash Flow | $-12,425 |
| Cash Flows From Investing Activities | |
| Change In Deposits | -2,000 |
| PPE Investments | -423 |
| Investing Cash Flow | $-2,423 |
| Cash Flows From Financing Activities | |
| Debt Issued | 500 |
| Debt Repayment | -897 |
| Common Stock Issued | 13 |
| Other Financing Activity | 13,160 |
| Financing Cash Flow | $12,776 |
| Beginning Cash Position | 4,287 |
| End Cash Position | 2,215 |
| Net Cash Flow | $-2,072 |
| Free Cash Flow | |
| Operating Cash Flow | -12,425 |
| Capital Expenditure | -423 |
| Free Cash Flow | -12,848 |